https://www.selleckchem.com/pr....oducts/proteinase-k.
RESULTS The mean number of ATX-101 treatments received was 1.8, with a mean injection volume of 0.8 ml per treatment per jowl. The majority of patients (98 percent) experienced an improvement in jowl appearance. Common adverse events were injection-site edema, numbness, tenderness, and bruising. Injection-site marginal mandibular nerve paresis and alopecia were experienced by three patients each; all events resolved without sequelae. CONCLUSIONS ATX-101 effectively reduced jowl fat and was well tolerated in this small cohort. Care
Like
Comment
Share
